PedAM
Pediatric Disease Annotations & Medicines
| diabetic angiopathy | ||||
| Disease ID | 1303 |
|---|---|
| Disease | diabetic angiopathy |
| Integrated Phenotype | (Waiting for update.) |
| Text Mined Phenotype | HPO | Name | Sentences' Count(Total Phenotypes:1) |
| Disease ID | 1303 |
|---|---|
| Disease | diabetic angiopathy |
| Manually Symptom | (Waiting for update.) |
| Text Mined Symptom | (Waiting for update.) |
Manually Genotype(Total Text Mining Genotypes:0) |
|---|
| (Waiting for update.) |
All Snps(Total Genotypes:3) | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| snpId | pubmedId | geneId | geneSymbol | diseaseId | sourceId | sentence | score | Year | geneSymbol_dbSNP | CHROMOSOME | POS | REF | ALT |
| rs2070600 | 24418399 | 177 | AGER | umls:C0011875 | BeFree | The study was designed to evaluate the association of -374T/A and -429T/C polymorphism in the promoter region and Gly82Ser polymorphism in exon 3 region of RAGE gene with diabetic vascular complications in Indian population. | 0.128987376 | 2013 | AGER | 6 | 32183666 | C | T |
| rs386556293 | 24418399 | 177 | AGER | umls:C0011875 | BeFree | The study was designed to evaluate the association of -374T/A and -429T/C polymorphism in the promoter region and Gly82Ser polymorphism in exon 3 region of RAGE gene with diabetic vascular complications in Indian population. | 0.128987376 | 2013 | NA | NA | NA | NA | NA |
| rs4880 | 20728955 | 6648 | SOD2 | umls:C0011875 | GAD | [Association between the rs4880 superoxide dismutase 2 (C>T) gene variant and coronary heart disease in diabetes mellitus.] | 0.004734064 | 2010 | SOD2 | 6 | 159692840 | A | G |
GWASdb Annotation(Total Genotypes:0) | |
|---|---|
| (Waiting for update.) | |
GWASdb Snp Trait(Total Genotypes:0) | |
|---|---|
| (Waiting for update.) | |
Mapped by lexical matching(Total Items:0) |
|---|
| (Waiting for update.) |
Mapped by homologous gene(Total Items:0) |
|---|
| (Waiting for update.) |
Chemical(Total Drugs:7) | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| CUI | ChemicalName | ChemicalID | CasRN | DiseaseName | DiseaseID | DirectEvidence | PubMedIDs | ||
| C0011875 | acetylcysteine | D000111 | 616-91-1 | diabetic angiopathies | MESH:D003925 | therapeutic | 25381014 | ||
| C0011875 | diltiazem | D004110 | 42399-41-7 | diabetic angiopathies | MESH:D003925 | therapeutic | 1833434 | ||
| C0011875 | enalapril | D004656 | 75847-73-3 | diabetic angiopathies | MESH:D003925 | therapeutic | 17970755 | ||
| C0011875 | metformin | D008687 | 657-24-9 | diabetic angiopathies | MESH:D003925 | therapeutic | 16385087 | ||
| C0011875 | rosiglitazone | C089730 | - | diabetic angiopathies | MESH:D003925 | therapeutic | 17970755 | ||
| C0011875 | streptozocin | D013311 | 18883-66-4 | diabetic angiopathies | MESH:D003925 | marker/mechanism | 19690068 | ||
| C0011875 | troglitazone | C057693 | 97322-87-7 | diabetic angiopathies | MESH:D003925 | therapeutic | 12601628 | ||
FDA approved drug and dosage information(Total Drugs:0) | |
|---|---|
| (Waiting for update.) | |
FDA labeling changes(Total Drugs:0) | |
|---|---|
| (Waiting for update.) | |